Gerresheimer AG (GXI.DE)
EUR 75.75
(-3.13%)
EUR 75.75
(-3.13%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 294.33 Million | 221.94 Million | 212.07 Million | 222.19 Million | 192.92 Million | 173.47 Million |
| Net Income | 120.08 Million | 102.19 Million | 87.24 Million | 89.88 Million | 82.68 Million | 131.12 Million |
| Depreciation & Amortization | 186.02 Million | 171.55 Million | 145.35 Million | 145.5 Million | 269.94 Million | 137.06 Million |
| Deferred income taxes | -6.46 Million | -2.62 Million | -4.77 Million | 4.29 Million | -20.83 Million | -54.87 Million |
| Stock-based compensation | 1.46 Million | 353 Thousand | 886 Thousand | 3.04 Million | 1.45 Million | 2.56 Million |
| Change in working capital | 31.77 Million | -61.61 Million | -3.86 Million | -22.91 Million | -139.25 Million | -35.06 Million |
| Other non-cash items | -43.55 Million | 12.08 Million | -12.77 Million | 2.38 Million | -1.06 Million | -59.65 Million |
| Investing Cash Flow | -307.43 Million | -256.18 Million | -197.03 Million | -157.03 Million | -203.21 Million | -286.93 Million |
| Investments in PPE | -328.03 Million | -238.07 Million | -203.62 Million | -173.07 Million | -164.55 Million | -114.56 Million |
| Acquisitions | -10.5 Million | -18.45 Million | -2.85 Million | -941 Thousand | -43.88 Million | -172.48 Million |
| Investment purchases | -10.5 Million | -18.45 Million | -2.85 Million | -1.03 Million | - | -162 Thousand |
| Sales/Maturities of investments | 10.5 Million | 18.45 Million | 2.85 Million | 1.03 Million | - | -5.06 Million |
| Other Investing Activities | 31.1 Million | 345 Thousand | 9.44 Million | 16.98 Million | 5.22 Million | 5.34 Million |
| Financing Cash Flow | 40.34 Million | 44.23 Million | 8.02 Million | -52.15 Million | -1.07 Million | -95.4 Million |
| Debt repayment | -707.64 Million | -652.56 Million | -252.09 Million | -501.62 Million | -343.17 Million | -433.21 Million |
| Dividends payments | -45.29 Million | -39.25 Million | -39.25 Million | -39.31 Million | -39.4 Million | -36.31 Million |
| Common Stock Repurchased | 45.29 Million | - | - | - | - | - |
| Common Stock Issuance | 271.61 Million | - | - | - | - | - |
| Other Financing Activities | 476.38 Million | 736.05 Million | 299.36 Million | 488.78 Million | 381.51 Million | 337.8 Million |
| Accounts receivables | -10.16 Million | -44.98 Million | 3.48 Million | -14.13 Million | 44.26 Million | -27.48 Million |
| Accounts payables | 63.93 Million | 63.92 Million | 50.66 Million | 3.27 Million | -153.04 Million | 19.36 Million |
| Inventory | -21.99 Million | -66.45 Million | -44.84 Million | -12.17 Million | -12.89 Million | -23.57 Million |
| Other working capital | 63.93 Million | -14.1 Million | -13.16 Million | 114 Thousand | -17.58 Million | -11.48 Million |
| Cash at beginning of period | 98.13 Million | 83.58 Million | 58.39 Million | 51.1 Million | 61.93 Million | 271.59 Million |
| Cash at end of period | 122.26 Million | 98.13 Million | 83.58 Million | 58.39 Million | 51.1 Million | 61.93 Million |
| Capital Expenditure | -328.03 Million | -238.07 Million | -203.62 Million | -173.07 Million | -164.55 Million | -114.56 Million |
| Effect of forex changes on cash | -3.12 Million | 4.54 Million | 2.12 Million | -5.71 Million | 525 Thousand | -788 Thousand |
| Net cash flow / Change in cash | 24.13 Million | 14.54 Million | 25.19 Million | 7.28 Million | -10.83 Million | -209.65 Million |
| Free Cash Flow | -33.7 Million | -16.13 Million | 8.45 Million | 49.12 Million | 28.37 Million | 58.9 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 27.66 Million | 32.46 Million | 13.42 Million | 120.08 Million | 42.28 Million | 28.73 Million |
| Depreciation & Amortization | 50.41 Million | 37.97 Million | 47.43 Million | 186.02 Million | 47.8 Million | 45.36 Million |
| Deferred income taxes | - | - | - | -6.46 Million | -6.46 Million | - |
| Stock-based compensation | - | - | - | 1.46 Million | 1.46 Million | - |
| Change in working capital | -3.64 Million | -49.58 Million | -24.33 Million | 31.77 Million | 70.22 Million | 74.32 Million |
| Other non-cash items | -3.17 Million | 112.66 Million | -9.26 Million | -43.55 Million | -10.95 Million | 10.5 Million |
| Investing Cash Flow | -76.05 Million | -86.05 Million | -106.56 Million | -307.43 Million | -97.74 Million | -87.89 Million |
| Investments in PPE | -82.08 Million | -82.25 Million | -115.58 Million | -328.03 Million | -96.67 Million | -83.63 Million |
| Acquisitions | -1000.00 | 269 Thousand | 1.71 Million | -10.5 Million | -1.4 Million | -9.1 Million |
| Investment purchases | -1000.00 | -9.33 Million | - | -10.5 Million | -1.4 Million | -9.1 Million |
| Sales/Maturities of investments | - | - | - | 10.5 Million | 1.4 Million | 9.1 Million |
| Other Investing Activities | -76.05 Million | 5.26 Million | 7.31 Million | 31.1 Million | 334 Thousand | 4.83 Million |
| Financing Cash Flow | 29.51 Million | 62.2 Million | 51.58 Million | 40.34 Million | -45.01 Million | -64.06 Million |
| Debt repayment | -76.56 Million | -73.23 Million | -58.09 Million | -707.64 Million | -204.77 Million | -90.45 Million |
| Dividends payments | -43.17 Million | -1000.00 | -2.25 Million | -45.29 Million | -13 Thousand | -43.1 Million |
| Common Stock Repurchased | - | - | - | 45.29 Million | - | - |
| Common Stock Issuance | - | - | - | 271.61 Million | - | - |
| Other Financing Activities | -3.88 Million | -5.28 Million | 3.5 Million | 476.38 Million | 159.77 Million | 69.49 Million |
| Accounts receivables | 9.17 Million | 1.98 Million | -5.48 Million | -10.16 Million | 7.58 Million | 3.4 Million |
| Accounts payables | -3.99 Million | -36.92 Million | 4.64 Million | 63.93 Million | 37.97 Million | 85.63 Million |
| Inventory | -8.82 Million | -14.63 Million | -23.49 Million | -21.99 Million | 24.67 Million | -14.71 Million |
| Other working capital | -3.99 Million | -1.91 Million | -538 Thousand | - | 10.11 Million | -3.49 Million |
| Cash at beginning of period | 78.29 Million | 106.49 Million | 122.26 Million | 98.13 Million | 115.74 Million | 109.95 Million |
| Cash at end of period | 99.9 Million | 96.46 Million | 95.12 Million | 122.26 Million | 122.26 Million | 115.74 Million |
| Capital Expenditure | -82.08 Million | -82.25 Million | -115.58 Million | -328.03 Million | -96.67 Million | -83.63 Million |
| Effect of forex changes on cash | -3.11 Million | -969 Thousand | 577 Thousand | -3.12 Million | -94 Thousand | -1.16 Million |
| Net cash flow / Change in cash | 21.6 Million | -10.03 Million | -27.14 Million | 24.13 Million | 6.51 Million | 5.79 Million |
| Free Cash Flow | -10.82 Million | -74.27 Million | -88.32 Million | -33.7 Million | 52.68 Million | 75.29 Million |
MKKGY
CJR-B
3154
7965
0HOH
BIOEX